27
Participants
Start Date
October 31, 2015
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Active RhinoChill
"The device is intended for use for the reduction of temperature via the nasal cavity.~The RhinoChill® System is a British Standards Institution Kite-Marked device that is currently commercially available in Europe. The RhinoChill® device is intended for temperature reduction in patients via the nasal cavity."
Placebo RhinoChill
The placebo RhinoChill device looks and functions in an identical way to the active RhinoChill. All components are used, however through some minor changes in the design of the device it now provides a sufficient placebo treatment to the patient.
Neurosciences department, Penrith Hospital, Cumbria Partnership NHS Foundation Trust, Penrith
CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST, 11 Norfolk Street, Sunderland SR1 1EA, Sunderland
The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough
Collaborators (1)
BeneChill, Inc
INDUSTRY
Cumbria Partnership NHS Foundation Trust
OTHER